Cocrystal Pharma Appoints Carol Brosgart, MD to its Board of Directors
Cocrystal Pharma announced the appointment of Dr. Carol Brosgart to its Board of Directors, effective August 12, 2026. Dr. Brosgart brings decades of experience in antiviral drug development from her tenure at Gilead Sciences and advisory roles at the CDC.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.